High Net Worth Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.39M Buy
15,153
+2
+0% +$797 1.34% 16
2026
Q2
$5.49M Buy
15,151
+61
+0.4% +$20.9K 1.16% 20
2026
Q1
$5.31M Buy
15,090
+2
+0% +$713 1.24% 15
2025
Q4
$4.94M Buy
15,088
+2
+0% +$634 1.14% 19
2025
Q3
$4.26M Buy
15,086
+2
+0% +$580 1.02% 24
2025
Q2
$4.21M Buy
15,084
+1
+0% +$283 1.12% 22
2025
Q1
$4.7M Hold
15,083
– – 1.33% 17
2024
Q4
$3.93M Hold
15,083
– – 1.1% 21
2024
Q3
$4.86M Sell
15,083
-1,725
-10% -$564K 1.33% 19
2024
Q2
$5.25M Hold
16,808
– – 1.59% 13
2024
Q1
$4.78M Buy
16,808
+1,218
+8% +$356K 1.5% 16
2023
Q4
$4.49M Hold
15,590
– – 1.67% 13
2023
Q3
$4.19M Sell
15,590
-70
-0.4% -$17.5K 1.68% 13
2023
Q2
$3.48M Sell
15,660
-71
-0.5% -$16.5K 1.35% 17
2023
Q1
$3.8M Sell
15,731
-36
-0.2% -$8.84K 1.55% 14
2022
Q4
$4.14M Sell
15,767
-36
-0.2% -$9.6K 1.61% 14
2022
Q3
$3.56M Hold
15,803
– – 1.52% 12
2022
Q2
$3.84M Buy
15,803
+920
+6% +$225K 1.6% 11
2022
Q1
$3.6M Hold
14,883
– – 1.31% 16
2021
Q4
$3.35M Buy
+14,883
New +$3.14M 1.17% 17

Other funds holding AMGN

High Net Worth Advisory Group's AMGN Position: Q3 2026 in Review

High Net Worth Advisory Group increased its Amgen (AMGN) stake by 0.01% in Q3 2026, buying an estimated $797 and bringing the position to 15,153 shares worth $6.39M. The position accounts for 1.34% of the portfolio, ranked #16.

High Net Worth Advisory Group first reported a position in AMGN in Q4 2021 and has held it in 20 quarters since. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • High Net Worth Advisory Group held 15,153 shares of Amgen worth $6.39M as of Q3 2026.
  • High Net Worth Advisory Group bought 2 Amgen shares in Q3 2026, an estimated $797.
  • Amgen made up 1.34% of High Net Worth Advisory Group's portfolio in Q3 2026, its #16 holding.
  • High Net Worth Advisory Group first reported a position in Amgen in Q4 2021 and has held it in 20 quarters since.
  • 2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on High Net Worth Advisory Group's 13F filing for Q3 2026, filed 26 Oct 2026.